Cargando…
BCL11A promotes myeloid leukemogenesis by repressing PU.1 target genes
The transcriptional repressor BCL11A is involved in hematological malignancies, B-cell development, and fetal-to-adult hemoglobin switching. However, the molecular mechanism by which it promotes the development of myeloid leukemia remains largely unknown. We find that Bcl11a cooperates with the pseu...
Autores principales: | Sunami, Yoshitaka, Yokoyama, Takashi, Yoshino, Seiko, Takahara, Tomoko, Yamazaki, Yukari, Harada, Hironori, Nakamura, Takuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941473/ https://www.ncbi.nlm.nih.gov/pubmed/34714913 http://dx.doi.org/10.1182/bloodadvances.2021004558 |
Ejemplares similares
-
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
por: Kuusanmäki, Heikki, et al.
Publicado: (2023) -
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor
resistance in acute myeloid leukemia
por: Lewis, Alexander C., et al.
Publicado: (2022) -
TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia
por: Sakoda, Teppei, et al.
Publicado: (2023) -
Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia
por: Yamato, Genki, et al.
Publicado: (2022) -
Repression of TRIM13 by chromatin assembly factor CHAF1B is critical for AML development
por: Dean, Sarai T., et al.
Publicado: (2023)